Introduction to the Special Issue on "Building Institutions for Priority Setting in Health".

Health technology assessment institutions organizations priority setting public agencies

Journal

Health systems and reform
ISSN: 2328-8620
Titre abrégé: Health Syst Reform
Pays: United States
ID NLM: 101697320

Informations de publication

Date de publication:
31 Dec 2023
Historique:
medline: 5 8 2024
pubmed: 5 8 2024
entrez: 5 8 2024
Statut: ppublish

Résumé

In the pursuit of universal health coverage, countries are invariably confronted with questions about which services to pay with public funds, to whom, and at what cost. Such priority-setting processes have major ramifications for the costs and benefits of care delivered. These processes are not just technical, but also highly political and organizational in nature and expressions of social values. This special issue focuses on building institutions for priority setting in health. These institutions serve a public purpose and are primarily concerned with conducting or using health technology assessment (HTA) to inform resource allocation decisions. We first define the concept of institutions for priority setting in health and the methodological considerations of assessing and evaluating these institutions. Next, we present key common themes and summarize key messages across the articles, including lessons learned and future challenges in building these institutions.

Identifiants

pubmed: 39101949
doi: 10.1080/23288604.2024.2377891
doi:

Types de publication

Introductory Journal Article Editorial

Langues

eng

Sous-ensembles de citation

IM

Pagination

2377891

Auteurs

Victoria Y Fan (VY)

Center for Global Development, Washington, DC, USA.
College of Social Sciences, University of Hawaii at Manoa, Honolulu, HI, USA.

Javier Guzman (J)

Center for Global Development, Washington, DC, USA.

Pete Baker (P)

Center for Global Development, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH